T1	p 28 52	advanced breast cancer .
T2	p 282 314	of advanced breast cancers which
T3	p 367 436	with the departments of medicine in eight French anticancer centres .
T4	p 516 520	work
T5	p 585 597	603 patients
T6	p 877 878	.
T7	p 1136 1147	240 cases .
T8	p 1226 1232	in all
T9	i 6 7	[
T10	i 241 262	programme evolved for
T11	i 698 710	chemotherapy
T12	i 717 741	consisted of vincristine
T13	i 770 791	with cyclophosphamide
T14	i 796 811	5-fluoro-uracil
T15	i 839 878	doxorubicine or/and with methotrexate .
T16	i 922 938	combined therapy
T17	i 945 957	doxorubicine
T18	i 1368 1380	chemotherapy
T19	o 521 522	.
T20	o 981 990	frequency
T21	o 1079 1088	quality ,
T22	o 1271 1281	palliation
T23	o 1288 1292	cure